Management Approach for Borderline Elevated FSH with Suboptimal Semen Parameters

Diagnostic Evaluation

The American Urological Association recommends measuring serum LH and prolactin immediately to determine if this represents primary testicular dysfunction (elevated LH) versus secondary hypogonadism (low/normal LH) in patients with borderline elevated FSH and suboptimal semen parameters 1, 2
If LH is low or low-normal with testosterone <150 ng/dL, obtaining pituitary MRI regardless of prolactin level to exclude non-secreting adenomas is suggested 1, 2
Testicular volumes below the normal lower limit of 15 mL, such as 9.5 mL and 12 mL, suggest some degree of testicular dysfunction that explains the borderline elevated FSH 3

Sperm concentration (56.9 million/mL) and total count (188.34 million) above WHO 2021 reference limits indicate preserved sperm production, according to the World Health Organization 3
Total motility of 43% is borderline, just meeting the WHO lower reference limit of 40%, with progressive motility also at 43%, as per WHO guidelines 3
Morphology at 3% normal forms is at the lower threshold of the WHO 2021 criteria, representing teratozoospermia, as defined by the World Health Organization 3

Testosterone therapy will suppress spermatogenesis and is absolutely contraindicated if fertility is a goal, as stated by the American Urological Association 1, 2
The elevated FSH with low-normal testosterone suggests the hypothalamic-pituitary-gonadal axis is already maximally stimulated to compensate for testicular dysfunction, according to the Endocrine Society 1, 2

Before initiating testosterone therapy, measuring hemoglobin/hematocrit and PSA (if age >40 years) is recommended by the American Urological Association 1, 2
Withhold testosterone if baseline hematocrit >50% until etiology is investigated, as suggested by the Endocrine Society 1, 2
Assessing cardiovascular risk factors including dyslipidemia, hypertension, diabetes, and smoking status is necessary before starting testosterone therapy, according to the American Heart Association 1, 2

Do not start testosterone therapy without determining fertility intentions, as this is irreversible suppression of spermatogenesis during treatment, as warned by the American Urological Association 1, 2
Do not assume normal fertility based on sperm concentration alone, as motility and morphology are also crucial factors, as emphasized by the World Health Organization 3
Do not proceed without measuring LH, as this distinguishes primary testicular failure from secondary hypogonadism, which have completely different treatment approaches, according to the Endocrine Society 1, 2

The American Urological Association suggests that a sperm concentration of 42 million/mL far exceeds the lower reference limit of 16 million/mL, indicating good fertility potential 4
The World Health Organization recommends that a total motile sperm count of 46 million is excellent, with a lower limit of 39 million total sperm 4
A semen volume of 3 mL is considered normal, with a reference range of 1.5-6 mL, according to the American Academy of Family Physicians 5, 4
The World Health Organization states that a motility of 46% meets the lower reference limit of 40% progressive + non-progressive motility 4

The Endocrine Society indicates that FSH levels between 7.6-10 IU/L typically indicate impaired spermatogenesis but not complete absence of sperm production 6, 7
The American College of Endocrinology suggests that addressing the underlying cause of elevated SHBG may normalize the hormonal profile 6, 7
High SHBG does not directly impair sperm production because spermatogenesis depends on intratesticular testosterone, which is 50-100 times higher than serum levels and maintained by LH stimulation, according to the American Society for Reproductive Medicine 6

The American Society for Reproductive Medicine recommends avoiding tobacco, limiting alcohol consumption, and avoiding recreational drugs to optimize fertility 4, 8
The Centers for Disease Control and Prevention suggest maintaining a healthy weight, with a BMI between 18.5-25, to optimize fertility 4, 8
The National Institute on Alcohol Abuse and Alcoholism advises limiting caffeine to less than 5 cups per day to minimize potential negative effects on fertility 8

The American Urological Association recommends considering referral to a male reproductive specialist if FSH remains >10 IU/L after addressing reversible factors 6, 7
The American Society for Reproductive Medicine suggests that genetic testing is not currently indicated for individuals with a sperm concentration >5 million/mL, but should be considered if future semen analysis shows severe oligospermia (<5 million/mL) 4, 6, 9

The American Urological Association recommends that men with excellent sperm count, like 80 million/mL, and normal testicular volume, consider a follow-up semen analysis and hormonal evaluation in 1-2 years before attempting conception, as their current parameters are reassuring 10

The European Society of Human Reproduction and Embryology suggests repeating semen analysis 1-2 years after the initial test to confirm stability of sperm parameters, as borderline FSH may indicate progressive decline over time, and this follow-up is crucial for men planning to conceive 11, 10

The American Academy of Family Physicians advises men to avoid gonadal toxins, such as heat exposure from hot tubs or saunas, as heat can damage spermatogenesis and impair fertility 12